Pfizer Inc and BioNTech‘s new proposal to the European Union, amid a glut of COVID-19 pictures, features a provision for member states to pay half worth, or about 10 euros ($11), for every of about 70 million cancelled doses, the Financial Times reported on Sunday.
The revised contract would permit the EU to improve to newer vaccines tailor-made to any future COVID-19 variants, the report added, citing folks near negotiations.
In January, Reuters reported talks between the EU and the 2 drugmakers aimed toward lowering as much as 500 million COVID-19 vaccine doses Brussels has dedicated to purchase this yr in return for the next worth.
The transfer comes because the bloc plans to revamp legal guidelines governing the $148 billion prescription drugs trade within the hope of reviving funding and boosting entry to inexpensive medicine at a time when well being budgets are drained by the prices of treating COVID-19.
Pfizer declined to touch upon the FT report however mentioned discussions had been performed ‘in good religion by all events’ whereas companion BioNTech and the European Medicines Agency (EMA) didn’t reply to Reuters’ requests for feedback.
Source: www.anews.com.tr
